INTRODUCTION: Parkinson's disease (PD) is a progressive neurodegenerative disease that primarily affects movement. The objective is to describe the mortality rate (MT) due to Parkinson's Disease in the period 2016 - 2023 in Chile. MATERIALS AND METHODS: Descriptive, observational and cross-sectional stud...
ABSTRACT Background: Parkinson's disease (PD) is a chronic disease that presents a multitude of symptoms, with symptoms of both motor and nonmotor nature. The Delphi method is widely used to create consensuses among experts in a field of knowledge. Objective: In order to reach a consensus on the valu...
RESUMO Objetivo identificar os fatores associados ao risco de quedas entre as pessoas com doença de Parkinson cadastradas na Associação Parkinson Santa Catarina. Método estudo transversal exploratório descritivo e de abordagem quantitativa, realizado com 53 pessoas cadastradas na Associação Park...
Accidentes por Caídas/estadística & datos numéricos,
Enfermedad de Parkinson/diagnóstico,
Factores de Riesgo,
Velocidad al Caminar,
Enfermedad Crónica,
Estudios Transversales,
Comorbilidad,
Pramipexol/uso terapéutico,
Grupos de Riesgo,
Levodopa/uso terapéutico,
Interacciones Farmacológicas,
Agudeza Visual
Abstract Background: Fatigue is a disabling symptom in the spectrum of Parkinson's disease (PD), affecting from 30% to 70% of the persons. Even though it is a common symptom, with negative repercussions for PD individuals, its correlation with balance is not established. Aim: The aims of this study wer...
BACKGROUND: The progression of Parkinson's disease is associated with complications, most of them preventable. AIM: To analyze hospitalizations with a diagnosis of Parkinson's disease in Chile, comparing the different health subsystems. MATERIAL AND METHODS: Analysis of hospital discharge database availa...
Parkinson's disease is a neurodegenerative disease understood as a complex syndrome with motor and non-motor symptoms, including sleep-related conditions, such as periodic limb
movements in sleep (PLMS). This paper presents issues regarding Parkinson's disease, motor and non-motor symptoms, sleep physiol...
ABSTRACT Parkinson's disease (PD), known since ancient times as paralysis agitans, was studied and described by James Parkinson in 1817 in his work "An Essay on the Shaking Palsy". Fifty years later, Charcot and his students delved into the disease, naming it as we know it today, as well as defining the ...
RESUMEN La enfermedad de Parkinson según la Organización Mundial de Salud, en el año 2016, afectó una persona por cada 100 mayores de 60 años, siendo en cifras absolutas 6,3 millones de personas, y para el año 2030 serán aproximadamente 12 millones de personas en todo el mundo con dicha patología...
Os derivados canabinoides podem ser vistos como novos potenciais terapêuticos para o tratamento da doença de Parkinson e Alzheimer. Assim, esta revisão teve como objetivo descrever os efeitos terapêuticos e adversos do uso de canabidiol e de delta-9-tetrahidrocanabinol nas doenças de Parkinson e de ...
Enfermedad de Parkinson/diagnóstico,
Enfermedad de Parkinson/tratamiento farmacológico,
Enfermedad de Alzheimer/diagnóstico,
Enfermedad de Alzheimer/tratamiento farmacológico,
Cannabinoides/uso terapéutico,
Encuestas y Cuestionarios,
Cannabinoides/efectos adversos,
Método Doble Ciego,
Cannabinoides/administración & dosificación,
Resultado del Tratamiento,
Experimentación Animal
